Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Glaucoma Study Investigating Standalone Canaloplasty, Randomized Controlled Trial: iTrack Advance (Nova Eye, Inc.) Compared to OMNI (Sight Sciences)

NCT05786196 is registered in ClinicalTrials.gov with Nova Eye, Inc. as lead sponsor.

NCT NCT05786196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05786196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Glaucoma Study Investigating Standalone Canaloplasty, Randomized Controlled Trial: iTrack Advance (Nova Eye, Inc.) Compared to OMNI (Sight Sciences)
Lead sponsor
Nova Eye, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
May 9, 2023
Completion date
December 31, 2026
Enrollment
86 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

primary open angle glaucoma